- call +1-201-465-4211
- email sales@mrinsights.biz
Ankylosing spondylitis is a form of chronic inflammation of the spine and the sacroiliac joints.
Scope of the Report:
This report focuses on the Ankylosing Spondylitis Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Ankylosing Spondylitis Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
There are 15 Chapters to deeply display the global Ankylosing Spondylitis Drug market.
Chapter 1, to describe Ankylosing Spondylitis Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Ankylosing Spondylitis Drug, with sales, revenue, and price of Ankylosing Spondylitis Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Ankylosing Spondylitis Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Ankylosing Spondylitis Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Ankylosing Spondylitis Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Ankylosing Spondylitis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Cimzia
1.2.2 Enbrel
1.2.3 Humira
1.2.4 Remicade
1.2.5 Simponi
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Ankylosing Spondylitis Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Wyeth
2.2.1 Business Overview
2.2.2 Ankylosing Spondylitis Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Takeda
2.3.1 Business Overview
2.3.2 Ankylosing Spondylitis Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Takeda Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Centocor
2.4.1 Business Overview
2.4.2 Ankylosing Spondylitis Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Centocor Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Schering-Plough
2.5.1 Business Overview
2.5.2 Ankylosing Spondylitis Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Mitsubishi Tanabe
2.6.1 Business Overview
2.6.2 Ankylosing Spondylitis Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Abbott
2.7.1 Business Overview
2.7.2 Ankylosing Spondylitis Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Abbott Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Eisai
2.8.1 Business Overview
2.8.2 Ankylosing Spondylitis Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Eisai Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Ankylosing Spondylitis Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Johnson & Johnson
2.10.1 Business Overview
2.10.2 Ankylosing Spondylitis Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Ankylosing Spondylitis Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Ankylosing Spondylitis Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Ankylosing Spondylitis Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Ankylosing Spondylitis Drug Market Analysis by Regions
4.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
4.3 Europe Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
4.5 South America Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5 North America Ankylosing Spondylitis Drug by Countries
5.1 North America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Ankylosing Spondylitis Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Ankylosing Spondylitis Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5.3 Canada Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6 Europe Ankylosing Spondylitis Drug by Countries
6.1 Europe Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Ankylosing Spondylitis Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Ankylosing Spondylitis Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.3 UK Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.4 France Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.5 Russia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
6.6 Italy Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Ankylosing Spondylitis Drug by Countries
7.1 Asia-Pacific Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Ankylosing Spondylitis Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Ankylosing Spondylitis Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.3 Japan Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.4 Korea Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.5 India Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8 South America Ankylosing Spondylitis Drug by Countries
8.1 South America Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Ankylosing Spondylitis Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Ankylosing Spondylitis Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Ankylosing Spondylitis Drug by Countries
9.1 Middle East and Africa Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Ankylosing Spondylitis Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Ankylosing Spondylitis Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.3 UAE Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Ankylosing Spondylitis Drug Sales and Growth Rate (2013-2018)
10 Global Ankylosing Spondylitis Drug Market Segment by Type
10.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Type (2013-2018)
10.2 Cimzia Sales Growth and Price
10.2.1 Global Cimzia Sales Growth (2013-2018)
10.2.2 Global Cimzia Price (2013-2018)
10.3 Enbrel Sales Growth and Price
10.3.1 Global Enbrel Sales Growth (2013-2018)
10.3.2 Global Enbrel Price (2013-2018)
10.4 Humira Sales Growth and Price
10.4.1 Global Humira Sales Growth (2013-2018)
10.4.2 Global Humira Price (2013-2018)
10.5 Remicade Sales Growth and Price
10.5.1 Global Remicade Sales Growth (2013-2018)
10.5.2 Global Remicade Price (2013-2018)
10.6 Simponi Sales Growth and Price
10.6.1 Global Simponi Sales Growth (2013-2018)
10.6.2 Global Simponi Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Ankylosing Spondylitis Drug Market Segment by Application
11.1 Global Ankylosing Spondylitis Drug Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
12 Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.1 Global Ankylosing Spondylitis Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Ankylosing Spondylitis Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.2 Europe Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.4 South America Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Ankylosing Spondylitis Drug Market Forecast (2018-2023)
12.3 Ankylosing Spondylitis Drug Market Forecast by Type (2018-2023)
12.3.1 Global Ankylosing Spondylitis Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2018-2023)
12.4 Ankylosing Spondylitis Drug Market Forecast by Application (2018-2023)
12.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Ankylosing Spondylitis Drug Picture
Table Product Specifications of Ankylosing Spondylitis Drug
Figure Global Sales Market Share of Ankylosing Spondylitis Drug by Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
